Elevated plasma levels of tumor necrosis factor (TNF)-α, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome

Journal of Infectious Diseases

Volumn 173, Issue 1, 1996, Pages 38-43

  Linderholm, Mats ^b   Ahlm, Clas ^b   Settergren, Bo ^b   Waage, Anders ^b   Tärnvik, Arne ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CRUSH SYNDROME; FEMALE; HANTAVIRUS; HEADACHE; HUMAN; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PUUMALA VIRUS; VIRUS HEMORRHAGIC FEVER;

EID: 0030051430     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.1.38     Document Type: Article

References (17)

1. Yanagihara R, Gajdusek DC. Hemorrhagic fever with renal syndrome: a historical perspective and review of recent advances. In: Gear JHS, ed. CRC handbook of viral and rickettsial hemorrhagic fevers. Boca Raton, FL: CRC Press, 1988:151-88.
2. Niklasson B, LeDuc J. Isolation of the nephropathia epidemica agent in Sweden. Lancet 1984;1:1012-3.
3. Lahdevirta J. Nephropathia epidemica in Finland: a clinical, historical and epidemiological study. Ann Clin Res 1971;3:1-154.
4. Settergren B, Juto P, Trollfors B, Wadell G, Norrby SR. Clinical characteristics of nephropathia epidemica in Sweden: prospective study of 74 cases. Rev Infect Dis 1989;11:921-7.
5. Mustonen J, Brummer-Korvenkontio M, Hedman K, Pasternack A, Pietilä K, Vaheri A. Nephropathia apudoma in Finland: a retrospective study of 126 cases. Scand J Infect Dis 1994;26:7-13.
6. Pilaski J, Feldmann H, Morzunov S, et al. Genetic identification of a new Puumala virus strain causing severe hemorrhagic fever with renal syndrome in Germany. J Infect Dis 1994;170:1456-62.
7. Linderholm M, Settergren B, Ahlm C, et al. A Swedish fatal case of nephropathia epidemica. Scand J Infect Dis 1991;23:501-2.
8. Zeier M, Zöller L, Weinreich T, et al. Severe hemorrhagic complications from infection with nephropathia epidemica strain of hantavirus. Clin Nephrol 1992;38:190-2.
9. Forslund T, Saltevo J, Anttinen J, et al. Complications of nephropathia epidemica: three cases. J Intern Med 1992;232:87-90.
10. Nichol ST, Spiropoulou CF, Morzunov S, et al. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 1993;262:914-7.
11. Duchin JS, Koster FT, Peters CJ, et al. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. N EngI J Med 1994;330:949-55.
12. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-29.
13. Espevik T, Nissen-Meyer J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 1986;95:99-105.
14. Liabakk NB, Sundan A, Lien E, et al. The release of p55 TNF receptor from U937 cells studied by a new p55 immunoassay. J Immunol Methods 1993;163:145-54.
15. Espevik T, Sundan A, Liabakk NB, Waage A. Cytokine interaction and clinical response. In: Kinney JM, Tucker HN, eds. Organ metabolism and nutrition. New York: Raven Press, 1994:165-80.
16. van Deventer SJH, Hart M, van der Poll T, Hack CE, Aarden LA. Endotoxin and tumor necrosis factor-α-induced interleukin-8 release in humans. J Infect Dis 1993;167:461-4.
17. Spriggs DR, Sherman ML, Michie H, et al. Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase I and pharmacologic study. J Natl Cancer Inst 1988;80:1039-44.